$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
Page: < prev 1 2 3 4 5 6 7 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 79.54 | 9,682 | 770,106 | 1,316 | |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 79.54 | 8,356 | 664,636 | 10,998 | |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 384.11 | 9,682 | 3,718,990 | 12,906 | 22.6 K to 12.9 K (-42.86 %) |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 79.54 | 9,682 | 770,106 | 22,588 | 12.9 K to 22.6 K (+75.02 %) |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 389.06 | 400 | 155,624 | 12,906 | 13.3 K to 12.9 K (-3.01 %) |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 388.57 | 7,956 | 3,091,496 | 13,306 | 21.3 K to 13.3 K (-37.42 %) |
| Aug 31 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 79.54 | 8,356 | 664,636 | 21,262 | 12.9 K to 21.3 K (+64.75 %) |
| Aug 28 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 8,000 | 0 | 763,467 | 771.5 K to 763.5 K (-1.04 %) |
| Aug 28 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 23,000 | 0 | 771,467 | 794.5 K to 771.5 K (-2.90 %) |
| Aug 28 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 16,000 | 0 | 794,467 | 810.5 K to 794.5 K (-1.97 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 67.85 | 18,000 | 1,221,300 | 159,954 | |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.57 | 500 | 192,285 | 810,467 | 811 K to 810.5 K (-0.06 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.78 | 2,634 | 1,010,865 | 810,967 | 813.6 K to 811 K (-0.32 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.74 | 7,023 | 2,687,977 | 813,601 | 820.6 K to 813.6 K (-0.86 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.08 | 7,445 | 2,844,611 | 820,624 | 828.1 K to 820.6 K (-0.90 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 380.41 | 398 | 151,404 | 828,069 | 828.5 K to 828.1 K (-0.05 %) |
| Aug 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 67.85 | 18,000 | 1,221,300 | 828,467 | 810.5 K to 828.5 K (+2.22 %) |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 63.95 | 3,722 | 238,022 | 0 | |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 382.61 | 3,722 | 1,424,063 | 2,847 | 6.6 K to 2.8 K (-56.66 %) |
| Aug 21 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 63.95 | 3,722 | 238,022 | 6,569 | 2.8 K to 6.6 K (+130.73 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Option Exercise | M | 206.94 | 483 | 99,952 | 1,932 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Buy | M | 206.94 | 483 | 99,952 | 874 | 391 to 874 (+123.53 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 79.54 | 1,256 | 99,902 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 1,880 | 99,988 | 0 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 79.54 | 1,256 | 99,902 | 52,732 | 51.5 K to 52.7 K (+2.44 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 1,880 | 99,988 | 51,486 | 49.6 K to 51.5 K (+3.79 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 67.85 | 20,000 | 1,357,000 | 177,954 | |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 386.40 | 100 | 38,640 | 810,467 | 810.6 K to 810.5 K (-0.01 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 385.60 | 7,383 | 2,846,902 | 810,567 | 818 K to 810.6 K (-0.90 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.94 | 4,477 | 1,723,394 | 817,950 | 822.4 K to 818 K (-0.54 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.81 | 4,461 | 1,712,175 | 822,487 | 826.9 K to 822.5 K (-0.54 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.28 | 3,579 | 1,368,184 | 826,888 | 830.5 K to 826.9 K (-0.43 %) |
| Aug 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 67.85 | 20,000 | 1,357,000 | 830,467 | 810.5 K to 830.5 K (+2.47 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 62.00 | 37,098 | 2,300,076 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 53.19 | 37,836 | 2,012,308 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 43.68 | 8,790 | 383,947 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 381.48 | 3,049 | 1,163,118 | 49,596 | 52.6 K to 49.6 K (-5.79 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 380.12 | 14,469 | 5,499,962 | 52,645 | 67.1 K to 52.6 K (-21.56 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 379.20 | 37,209 | 14,109,701 | 67,114 | 104.3 K to 67.1 K (-35.67 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 377.84 | 28,997 | 10,956,290 | 104,323 | 133.3 K to 104.3 K (-21.75 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 62.00 | 37,098 | 2,300,076 | 133,320 | 96.2 K to 133.3 K (+38.55 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 53.19 | 37,836 | 2,012,308 | 96,222 | 58.4 K to 96.2 K (+64.80 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 43.68 | 8,790 | 383,947 | 58,386 | 49.6 K to 58.4 K (+17.72 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 67.85 | 1,107 | 75,110 | 769 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 79.54 | 698 | 55,519 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 67.85 | 1,107 | 75,110 | 9,652 | 8.5 K to 9.7 K (+12.95 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 79.54 | 698 | 55,519 | 8,545 | 7.8 K to 8.5 K (+8.90 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Sell | S | 377.51 | 100 | 37,751 | 7,847 | 7.9 K to 7.8 K (-1.26 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Sell | S | 377.50 | 2,676 | 1,010,190 | 7,947 | 10.6 K to 7.9 K (-25.19 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 70.54 | 5,629 | 397,070 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 385.11 | 5,629 | 2,167,803 | 304 | 5.9 K to 304 (-94.88 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 70.54 | 5,629 | 397,070 | 5,933 | 304 to 5.9 K (+1,851.64 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 378.08 | 1,111 | 420,047 | 304 | 1.4 K to 304 (-78.52 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 19,940 | 1,236,280 | 0 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 25,000 | 1,550,000 | 19,940 | |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.48 | 2,379 | 914,680 | 810,467 | 812.8 K to 810.5 K (-0.29 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.66 | 5,704 | 2,188,415 | 812,847 | 818.6 K to 812.8 K (-0.70 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.86 | 11,857 | 4,539,507 | 818,550 | 830.4 K to 818.6 K (-1.43 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 19,940 | 1,236,280 | 830,407 | 810.5 K to 830.4 K (+2.46 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 384.19 | 256 | 98,353 | 810,467 | 810.7 K to 810.5 K (-0.03 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 383.44 | 200 | 76,688 | 810,723 | 810.9 K to 810.7 K (-0.02 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 382.68 | 128 | 48,982 | 810,923 | 811.1 K to 810.9 K (-0.02 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 381.53 | 1,877 | 716,137 | 811,051 | 812.9 K to 811.1 K (-0.23 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 380.26 | 1,816 | 690,550 | 812,928 | 814.7 K to 812.9 K (-0.22 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 379.26 | 14,423 | 5,470,011 | 814,744 | 829.2 K to 814.7 K (-1.74 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 377.93 | 6,300 | 2,380,959 | 829,167 | 835.5 K to 829.2 K (-0.75 %) |
| Aug 18 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 25,000 | 1,550,000 | 835,467 | 810.5 K to 835.5 K (+3.08 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Option Exercise | M | 0.00 | 193 | 0 | 7,481 | |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Payment of Exercise | F | 395.71 | 97 | 38,384 | 49,596 | 49.7 K to 49.6 K (-0.20 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | EVP, CFO & Treasure ... | Buy | M | 0.00 | 193 | 0 | 49,693 | 49.5 K to 49.7 K (+0.39 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President and CEO | Option Exercise | M | 0.00 | 385 | 0 | 10,343 | |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President and CEO | Payment of Exercise | F | 395.71 | 179 | 70,832 | 44,333 | 44.5 K to 44.3 K (-0.40 %) |
| Aug 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President and CEO | Buy | M | 0.00 | 385 | 0 | 44,512 | 44.1 K to 44.5 K (+0.87 %) |
| Aug 03 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 371.10 | 13 | 4,824 | 2,847 | 2.8 K to 2.8 K (+0.46 %) |
| Aug 03 2020 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 371.10 | 42 | 15,586 | 904 | 862 to 904 (+4.87 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 79.54 | 1,256 | 99,902 | 0 | |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 62.00 | 12,814 | 794,468 | 0 | |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 308.88 | 4,867 | 1,503,299 | 12,892 | 17.8 K to 12.9 K (-27.41 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 307.99 | 3,296 | 1,015,133 | 17,759 | 21.1 K to 17.8 K (-15.65 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 306.99 | 3,948 | 1,211,977 | 21,005 | 25 K to 21 K (-15.82 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 306.21 | 1,600 | 489,935 | 25,003 | 26.6 K to 25 K (-6.01 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 304.76 | 359 | 109,410 | 26,603 | 27 K to 26.6 K (-1.33 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 79.54 | 1,256 | 99,902 | 26,962 | 25.7 K to 27 K (+4.89 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 62.00 | 12,814 | 794,468 | 25,706 | 12.9 K to 25.7 K (+99.39 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 63.95 | 7,722 | 493,822 | 0 | |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 308.08 | 1,690 | 520,658 | 0 | 1.7 K to 0 (-100.00 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 307.02 | 3,052 | 937,028 | 1,690 | 4.7 K to 1.7 K (-64.36 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 306.12 | 2,980 | 912,235 | 4,742 | 7.7 K to 4.7 K (-38.59 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 7,722 | 0 | 7,722 | 0 to 7.7 K |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 7,722 | 0 | 0 | 7.7 K to 0 (-100.00 %) |
| Jun 02 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 63.95 | 7,722 | 493,822 | 7,722 | 0 to 7.7 K |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Sell | S | 301.00 | 2,690 | 809,690 | 10,112 | 12.8 K to 10.1 K (-21.01 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 63.95 | 4,000 | 255,800 | 3,422 | |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | S | 295.61 | 4,000 | 1,182,433 | 2,834 | -1,166 to 2.8 K (-343.05 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 63.95 | 4,000 | 255,800 | 6,834 | 2.8 K to 6.8 K (+141.14 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 294.99 | 10,000 | 2,949,900 | 10,000 | 20 K to 10 K (-50.00 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 297.29 | 23,000 | 6,837,670 | 20,000 | 43 K to 20 K (-53.49 %) |
| May 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 297.18 | 5,000 | 1,485,900 | 43,000 | 48 K to 43 K (-10.42 %) |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 63.95 | 7,422 | 474,637 | 300 | |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 64.69 | 5,974 | 386,458 | 0 | |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 286.66 | 7,422 | 2,127,565 | 14,696 | 22.1 K to 14.7 K (-33.56 %) |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 63.95 | 7,422 | 474,637 | 22,118 | 14.7 K to 22.1 K (+50.50 %) |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 286.66 | 5,974 | 1,712,487 | 14,696 | 20.7 K to 14.7 K (-28.90 %) |
| May 15 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 64.69 | 5,974 | 386,458 | 20,670 | 14.7 K to 20.7 K (+40.65 %) |
| May 13 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 293.41 | 30,000 | 8,802,300 | 48,000 | 78 K to 48 K (-38.46 %) |
| May 13 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 297.80 | 20,000 | 5,956,000 | 78,000 | 98 K to 78 K (-20.41 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 64.24 | 4,028 | 258,759 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 79.54 | 11,110 | 883,689 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 62.00 | 1,126 | 69,812 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 299.30 | 4,028 | 1,205,559 | 17,772 | 21.8 K to 17.8 K (-18.48 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 64.24 | 4,028 | 258,759 | 21,800 | 17.8 K to 21.8 K (+22.66 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 298.75 | 11,110 | 3,319,088 | 17,772 | 28.9 K to 17.8 K (-38.47 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 79.54 | 11,110 | 883,689 | 28,882 | 17.8 K to 28.9 K (+62.51 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 298.29 | 1,126 | 335,869 | 17,772 | 18.9 K to 17.8 K (-5.96 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 62.00 | 1,126 | 69,812 | 18,898 | 17.8 K to 18.9 K (+6.34 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 21,130 | 1,310,060 | 44,940 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 293.40 | 2,601 | 763,125 | 810,467 | 813.1 K to 810.5 K (-0.32 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 292.44 | 3,440 | 1,005,993 | 813,068 | 816.5 K to 813.1 K (-0.42 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 291.42 | 9,953 | 2,900,451 | 816,508 | 826.5 K to 816.5 K (-1.20 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 290.59 | 5,136 | 1,492,490 | 826,461 | 831.6 K to 826.5 K (-0.62 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 21,130 | 1,310,060 | 831,597 | 810.5 K to 831.6 K (+2.61 %) |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 0.00 | 370 | 0 | 663 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 283.59 | 487 | 138,108 | 487 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 141 | 0 | 1,740 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 370 | 0 | 1,599 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 370 | 0 | 3,163 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | A | 0.00 | 370 | 0 | 18,115 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 0.00 | 370 | 0 | 1,261 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 283.59 | 1,279 | 362,712 | 1,279 | |
| May 08 2020 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 0.00 | 370 | 0 | 2,328 | |
| Feb 27 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 79.54 | 1,256 | 99,902 | 0 | |
| Feb 27 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 79.54 | 1,256 | 99,902 | 810,467 | 809.2 K to 810.5 K (+0.16 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 62.00 | 23,000 | 1,426,000 | 66,070 | |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 280.40 | 400 | 112,160 | 137,600 | 138 K to 137.6 K (-0.29 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 650 | 0 | 809,211 | 809.9 K to 809.2 K (-0.08 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 290.24 | 928 | 269,340 | 809,861 | 810.8 K to 809.9 K (-0.11 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.67 | 300 | 86,600 | 810,789 | 811.1 K to 810.8 K (-0.04 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 287.72 | 1,424 | 409,708 | 811,089 | 812.5 K to 811.1 K (-0.18 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 286.81 | 4,600 | 1,319,344 | 812,513 | 817.1 K to 812.5 K (-0.56 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 285.98 | 8,375 | 2,395,083 | 817,113 | 825.5 K to 817.1 K (-1.01 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 284.04 | 1,400 | 397,662 | 825,488 | 826.9 K to 825.5 K (-0.17 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 282.69 | 1,000 | 282,690 | 826,888 | 827.9 K to 826.9 K (-0.12 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 281.30 | 400 | 112,520 | 827,888 | 828.3 K to 827.9 K (-0.05 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 280.34 | 4,573 | 1,282,004 | 828,288 | 832.9 K to 828.3 K (-0.55 %) |
| Feb 24 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 62.00 | 23,000 | 1,426,000 | 832,861 | 809.9 K to 832.9 K (+2.84 %) |